The investigators have identified a subregion of chromosome 3q that undergoes tumor-specific loss of constitutional heterozygosity (LoH) at high frequency during osteosarcoma tumorigenesis. LoH is frequently associated with the presence of tumor suppressor gene within the region of LoH. A bone dysmorphology syndrome Brachmann-DeLange syndrome also maps to this region suggesting that the tumor suppressor gene and the locus for the dysmorphology syndrome may be the same gene. Thus the specific aims of this proposal are: 1) To isolate candidate cDNAs from within the D3S1212-D3S1246 region; 2) To character the candidate cDNAs for expression patterns consistent with osteosarcoma tumor suppressor gene activity; 3) To conduct mutational analysis in osteosarcoma tumors on those candidate cDNAs with expression patterns consistent with osteosarcoma tumor suppressor gene activity; 4) to conduct mutational analysis for inherited mutations in familial osteosarcoma and Brachmann-DeLange syndrome patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA074802-04
Application #
6124557
Study Section
Mammalian Genetics Study Section (MGN)
Program Officer
Okano, Paul
Project Start
1997-12-20
Project End
2001-11-30
Budget Start
1999-12-01
Budget End
2001-11-30
Support Year
4
Fiscal Year
2000
Total Cost
$194,528
Indirect Cost
Name
University of Connecticut
Department
Type
Schools of Medicine
DUNS #
022254226
City
Farmington
State
CT
Country
United States
Zip Code
06030
Deshpande, A M; Akunowicz, J D; Reveles, X T et al. (2007) PHC3, a component of the hPRC-H complex, associates with E2F6 during G0 and is lost in osteosarcoma tumors. Oncogene 26:1714-22